Auditory effects after organ preservation protocol for laryngeal/ hypopharyngeal carcinomas

Archives of Otolaryngology - Head and Neck Surgery

Volumn 130, Issue 11, 2004, Pages 1265-1268

  Liberman, Patricia Helena Pecora ^a   Schultz, Christiane ^a   Gomez, M Valéria Schmidt Goffi ^a   Carvalho, André Lopes ^a   Pellizzon, Antonio Cassio Assis ^a   Testa, José Ricardo ^a   Feher, Olavo ^a,b   Kowalski, Luiz Paulo ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b Hosp do Câncer AC Camargo ^*

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PACLITAXEL;

ACOUSTIC IMPEDANCE; ADULT; ARTICLE; AUDIOLOGY; AUDITORY THRESHOLD; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEARING ACUITY; HEARING LOSS; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; MALE; ORGAN PRESERVATION; PHASE 2 CLINICAL TRIAL; PREVALENCE; PROSPECTIVE STUDY; PURE TONE AUDIOMETRY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; HEARING LOSS, SENSORINEURAL; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE;

EID: 8844273270     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.130.11.1265     Document Type: Article

References (19)

1. Wang SJ, Wang MB, Calcaterra TC. Radiotherapy followed by neck dissection for small head and neck cancers with advanced cervical metastases. Ann Otol Rhinol Laryngol. 1999;108:128-131.
2. Cheng PW, Young YH, Lou PJ. Patulous Eustachian tube in long-term survivors of nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol. 1999;108:201-204.
3. Smouha EE, Karmody CS. Non-osteitic complications of therapeutic irradiation to the temporal bone. Am J Otol. 1995;16:83-87.
4. Varghese G, Sahota JS, Hazarika P, Hajashekar B. Hearing anomalies following radiation therapy for head and neck cancers. Indian J Exp Biol. 1996;34:878-879.
5. Moretti JA. Sensorineural hearing loss following radiotherapy to the nasopharynx. Laryngoscope. 1976;86:598-602.
6. Oliveira JAA. Ototoxicidade. In: Costa SS, Cruz OLM, Oliveira JAA. Otorrinolaringologia. Porto Alegre, Brazil: Editera Arles Medicas; 1994.
7. Pedalini MEB, Cruz OLM, Bensadon RL. Aspectos audiológicos na radioterapia, na quimioterapia em tumores do ângulo ponto cerebelar. In: Angelis EC, Furia CLB, Mourão LF, Kowalski LP, eds. Atuação da Fonoaudiologia no Câncer de Cabeça e Pescoço. São Paulo, Brazil: Editora Lovise; 2000.
8. Kenyon EL, Leidenheim SE, Zwillenberg S. Speech discrimination in the sensorineural hearing loss patient: how is it affected by background noise? Mil Med. 1998;163:647-650.
9. Kubo T, Sakashita T, Kusuki M, et al. Sound lateralization and speech discrimination in patients with sensorineural hearing loss. Acts Otolaryngol Suppl. 1998; 538:63-69.
10. Amercican Speech-Language-Hearing Association (ASHA). Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy. ASHA. 1994;36(suppl 12):11-19.
11. Martensen K, Anthony BT. Crânio e ossos do crânio. In: Bontrages KL. Tratado de Técnica Radiológica e Base Anatômica. 4th ed. Rio de Janeiro, Brazil: Koogan; 1997.
12. Schweitzer VG. Ototoxicty of chemotherapeutic agents. Otolaryngol Clin North Am. 1993;26:759-789.
13. Ozturan O, Jerger J, Lew H. Monitoring of cisplatin ototoxicity by distortion-product otoacoustic emissions. Auris Nasus Larynx. 1996;23:147-151.
14. Rybak LP. Ototoxicity and antineoplastic drugs. Curr Opin Otolaryngol Head Neck Surg. 1999;7:239-243.
15. Dreschler WA, Urbanus NAM, Van der Hulst RJ. High frequency audiometry in prospective clinical research of ototoxicity due to platinum dericatives. Ann Otol Rhinol Laryngol. 1988;97:133-137.
16. Cavaletti G, Bogliun G, Crespi V, et al. Neurotoxicity and ototoxicity of cisplatin plus paclitaxel in comparison to cisplatin plus cyclophosphamide in patients with epithelial ovarian cancer. J Clin Oncol. 1997;15:199-206.
17. Chen WC, Liao CT, Wang CC, et al. Radiation-induced hearing impairment in patients treated for malignant parotid tumor. Ann Otol Rhinol Laryngol. 1999; 108:1159-1164.
18. Lacava JA, Ferreyra R, Leone BA, Losada C, Elem YL, Vallejo CT. High dose of cisplatin as neoadjuvant organ-preserving chemotherapy for squamous cell carcinoma of the larynx. Cancer J Sci Am. 1996;2:46.
19. Hoistad DL, Ondrey FG, Mutlu C, Schachern PA, Paparella MM, Adams GL. Histopathology of human temporal bone after cis-platinum, radiation, or both. Otolaryngol Head Neck Surg. 1998;118:825-832.